Stemline Therapeutics Stock Price (NASDAQ:STML)

Add to My Stocks
$10.2 $0.1 (0.99%) STML stock closing price Jul 21, 2017 (Closing)
Prev Close* : $10.10
Market Cap:
Day Low: $10.1
52 Week Low: $5.50
Open: $10.2
Volume: 136566
Day High: $10.45
52 Week High: $14.60

Latest Stock Market News

Latest Articles

Stemline Therapeutics News - From Partners

STML Stockcharts

View STML PE ratio, PS ratio stocks charts and compare with peers.
STML Chart
Note: Compare Stemline Therapeutics stock price history with the index and industry peers.

Stemline Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Stemline Therapeutics Financial Ratios

Asset Turnover

STML Industry Peers

Company Price Change (%)
Obseva Sa (OBSV)8.310.14 (1.66%)
Clearside Biomedical (CLSD)9.930.11 (1.12%)
Karyopharm Therapeutics (KPTI)9.340.04 (0.43%)
Celgene (CELG)137.741.43 (1.05%)
Agenus (AGEN)5.050.02 (0.4%)
Immunocellular Therapeutics (IMUC)0.380.01 (2.56%)
Seattle Genetics (SGEN)54.390.25 (0.46%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)43.412.48 (6.06%)
Mirati Therapeutics (MRTX)4.90.25 (5.38%)
Cytokinetics (CYTK)14.50.65 (4.69%)
Fortress Biotech (FBIO)4.870.2 (4.28%)
Revance (RVNC)23.750.95 (4.17%)
BioDelivery Sciences (BDSI)3.250.1 (3.17%)
Compugen (CGEN)3.550.1 (2.9%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Peregrine Pharma (PPHM)4.60.62 (11.88%)
Alimera Sciences (ALIM)1.450.13 (8.23%)
Trevena (TRVN)2.7550.22 (7.41%)
Vital Therapies (VTL)2.650.15 (5.36%)
ALBIREO PHARMA (ALBO)26.211.41 (5.1%)
Achillion Pharma (ACHN)4.110.21 (4.86%)
MannKind (MNKD)1.30.06 (4.41%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017

Stemline Therapeutics Inc Stock News - Partner Headlines

Stemline Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.04M0.65M0.33M0.07M-
Net Income-38.3M-37.24M-28.82M-24.19M-6.27M
Total Operating Expense39.91M38.27M29.32M24.04M6.46M
view Stemline Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets68.11M98.21M60.49M85.28M5.02M
Total Liabilities10.39M10.1M5.08M5.65M7.53M
Shareholders Equity57.72M88.11M55.41M79.62M-2.5M
view Stemline Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities0.44M6M-1.71M2.66M1.53M
Net Cash From (Used By) Operating Activities-30.09M-25.58M-25.71M-16.11M-4.12M
Increase (Decrease) In Prop Plant And Equipment-0.01M-0.01M--0.46M-
view Stemline Therapeutics Inc cashflow statement

Stemline Therapeutics Stock Message Board

Stemline Therapeutics stock price ended the last trading day at 10.2. Stemline Therapeutics market capitalization is 253.67M and it represents the total market value of STML stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Stemline Therapeutics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Stemline Therapeutics is worth a lot, it will most likely be reflected in an inflated Stemline Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 136566 STML shares were traded yesterday, and Stemline Therapeutics stock chart shows that the STML stock quote hit a day high of 10.45 and day low of 10.1. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of STML, view Stemline Therapeutics stock price history.